Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|---|---|---|---|
| Income Tax Disclosure [Abstract] | |||
| Share-based Compensation | $ 5,282 | $ 5,383 | |
| Depreciation and Amortization | 451 | (23) | |
| Accrued Liability | 279 | 307 | |
| Net Operating Loss Carry-forwards | 28,270 | 25,146 | |
| R&D Credit Carryforwards | 4,469 | 4,432 | |
| R&D Section 174 Costs | 7,511 | 5,953 | |
| Other | 31 | 1 | |
| IPR&D | (637) | (851) | |
| ROU Asset | (476) | (870) | |
| ROU Liability | 811 | 996 | |
| Total Deferred tax assets | 45,991 | 40,474 | |
| Valuation allowance | (46,248) | (40,815) | $ (34,388) |
| Net deferred tax asset (liability) | $ (257) | $ (341) |
| X | ||||||||||
- Definition Deferred tax assets depreciation and amortization. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets Right-Of-Use asset. No definition available.
|
| X | ||||||||||
- Definition ROU Liability. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|